Truth be told, one of the biggest draws to using CBD oil for pain has been the fact that it has little distinguishable side-effects or contraindications with other medications. In fact, in a massive report that was published by the World Health Organization during last year’s 2017 Expert Committee on Drug Dependence, it was (finally) declared to the world that CBD is a “safe, well tolerated [compound, which] is not associated with any significant adverse public health effects.”
The undisputed champion of terpenes is the cannabis plant. For so many, the blend of terpenes defines the cannabis experience. They can tell a story of composition, define a strain or pinpoint an origin. In fact, for many cannabis grow operations, retaining high terpene profiles is a driving goal. Not only do terpenes dictate flavor profiles, but also the effects – and science is just now beginning to explore the beneficial mechanisms at play.
Moreover, a patient survey conducted by Project CBD, declared that “…cannabis appears to be an effective pain management tool with few negative side effects.” The study went on to say that a “…significant decrease in opiate usage among elderly patients while taking medical cannabis [was observed during trial].” In short, it has been portrayed clearly numerous times through valid and well-publicized clinical studies that cannabis is a practical option in terms of efficient pain management.
Generalized pain, for instance, has dozens upon dozens of high profile research and clinical studies that have been carried out in universities and laboratories around the globe. One of the most well-publicized of these studies took place back in 2008, in which results determined that “cannabinoid analgesics (pain relievers) have generally been well tolerated in clinical trials … with acceptable adverse event profiles (meaning acceptable effectiveness for practical use).

The use of CBD is safe, with a few non-serious potential side effects. This is shown by the studies and that is what doctors and scientists say. Most CBD users do not experience any of these side effects. Even in very high doses of CBD there is no toxicity. However, everyone is unique and the body chemistry of each individual is slightly different.
Because our hemp oil products are categorized as dietary supplements in the United States, we comply with the FDA’s DSHEA guidelines and cannot endorse any specific medical benefits of CBD or our CBD oil. To further comply with FDA regulations, HempMeds® does not list a Recommended Daily Intake (RDI) of our own, nor do we provide a Daily Value (%DV) for any of our products. We encourage you to browse the thousands of reputable studies regarding CBD published online and talk with your doctor to see if a CBD oil supplement is right for you.
Statement from FDA Commissioner Scot Gottlieb, M.D., on signing of the Agriculture Improvement Act and the agency's regulation of products containing cannabis and cannabis-derived compounds. U.S. Food and Drug Administration Web site. Available at: https://www.fda.gov/news-events/press-announcements/statement-fda-commissioner-scott-gottlieb-md-signing-agriculture-improvement-act-and-agencys. (Accessed May 7, 2019).
CBD oil may be of some benefit to those with addiction, suggests a review published in the journal Substance Abuse in 2015. In their analysis of 14 previously published studies, scientists determined that CBD may have therapeutic effects in people with opioid, cocaine, and/or psychostimulant addiction. They also found that CBD may be beneficial in the treatment of cannabis and tobacco addiction. There is some evidence that CBD may block or reduce the effects of THC on the mind.

Third-Party Testing: Once a CBD oil is manufactured, CBD oil companies will often submit their products for third-party tests, which are conducted by non-company personnel to ensure the product is safe for public consumption and meets quality standards.CBD oils should always be accompanied with information about third-party tests; best practice is to avoid oils that do not supply these details.
×